Abstract
The development of malignancies after solid organ transplantation represents an increasing clinical problem complicating the long-term follow-up of transplant recipients. In this case report the authors describe the rare triple combination of a simultaneous hepatocellular carcinoma with a glucagonoma and a splenic hamartoma in a renal allograft recipient. It is not only the first published report of a glucagonoma occurring after renal transplantation but serves also as an illustration of the therapeutic decision making in the setting of the immune-compromised host. This case report also illustrates the different imaging modalities that can be used for the diagnosis of neuroendocrine tumors.
Copyright 2002 by the National Kidney Foundation, Inc.
MeSH terms
-
Carcinoma, Hepatocellular / diagnosis
-
Carcinoma, Hepatocellular / surgery
-
Female
-
Glucagonoma / diagnosis
-
Glucagonoma / drug therapy
-
Glucagonoma / surgery
-
Hamartoma / diagnosis
-
Hamartoma / drug therapy
-
Hamartoma / surgery
-
Humans
-
Kidney Transplantation / methods*
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / surgery
-
Middle Aged
-
Neoplasms / diagnosis*
-
Neoplasms / drug therapy
-
Neoplasms / surgery*
-
Neoplasms, Multiple Primary / diagnosis
-
Neoplasms, Multiple Primary / drug therapy
-
Neoplasms, Multiple Primary / surgery
-
Pancreatic Neoplasms / diagnosis
-
Pancreatic Neoplasms / drug therapy
-
Pancreatic Neoplasms / surgery
-
Splenic Neoplasms / diagnosis
-
Splenic Neoplasms / drug therapy
-
Splenic Neoplasms / surgery